Zobrazeno 1 - 9
of 9
pro vyhledávání: '"T M, Zimmerman"'
Autor:
R. A. Buerki, J. M. Collins, Vinai Gondi, Rimas V. Lukas, S.J. Chmura, T. M. Zimmerman, Greg Kauffmann
Publikováno v:
Neuro-Oncology. 19:iii102-iii102
Central nervous system invasion of multiple myeloma is a rare extra-medullary form of the disease, presenting as intraparenchymal lesions, leptomeningeal disease, or via direct dural invasion. Survival of leptomeningeal myelomatosis in historical ser
Autor:
T. M. Zimmerman
Publikováno v:
Oncologic Therapies ISBN: 9783642628184
Oncologic Therapies ISBN: 9783540781080
Oncologic Therapies ISBN: 9783540781080
Plasma cell dyscrasias are a heterogeneous group of disorders characterized by the accumulation of monoclonal plasma cells or plasmacytoid B lymphocytes and are frequently associated with the overproduction of a monoclonal immunoglobulin product, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b0d9945a5334f1ae28117a38b16fa7d
https://doi.org/10.1007/978-3-642-55780-4_23
https://doi.org/10.1007/978-3-642-55780-4_23
Publikováno v:
The Journal of urology. 165(4)
Publikováno v:
Journal of clinical apheresis. 14(1)
A subgroup of patients with refractory Hodgkin's (HD) or non-Hodgkin's (NHL) lymphoma may be cured with high-dose chemotherapy and peripheral blood progenitor cell rescue. To investigate the relationship of adequate leukapheresis yield and time cours
Autor:
T M, Zimmerman, S F, Williams
Publikováno v:
Cytokines, cellularmolecular therapy. 4(4)
After extensive preclinical work, hematopoietic cellular therapy has recently entered a new era of clinical trials involving ex vivo cultured cells. The evolution of hematopoietic cell culture from clonogenic assays to large-scale static culture syst
Publikováno v:
Cancer. 83(8)
Paclitaxel, an effective chemotherapeutic agent in the management of breast carcinoma, may have activity in women whose disease has recurred after high dose chemotherapy. With this is mind the authors explored the addition of a 120-hour continuous in
Publikováno v:
Bone marrow transplantation. 15(6)
The restoration of hematopoiesis after high-dose chemotherapy may be accelerated by the use of stem cells from the bone marrow (BM) or peripheral blood. Numerous reports utilizing mobilized peripheral blood progenitor cells (PBPC) for stem cell rescu
Publikováno v:
Bone marrow transplantation. 15(3)
The duration of neutropenia and thrombocytopenia after high-dose chemotherapy has improved since the introduction of myeloid growth factors and peripheral blood progenitor cells (PBPC), yet there remains a subset of patients who have delayed hematopo
Publikováno v:
Progress in clinical and biological research. 389